Ionis to Present at 43rd Annual J.P. Morgan Healthcare Conference

PR NewswireJan 9 05:11

Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected

BenzingaJan 8 01:48

Bernstein Maintains Ionis Pharmaceuticals(IONS.US) With Hold Rating, Cuts Target Price to $51

Futu NewsJan 7 17:32 · Ratings

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

BenzingaJan 4 02:08

Insider Trades: Walmart, Teva Among Notable Names This Week

Seeking AlphaDec 29, 2024 00:03

Are Investors Undervaluing Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) By 31%?

Simply Wall StDec 27, 2024 20:29